Business
Single-shot Johnson & Johnson vaccine ‘highly effective’ in preventing severe COVID-19 – SBS News
In large clinical trials, the Johnson & Johnson vaccine’s efficacy against severe disease was 85.9 per cent in the United States, 81.7 per cent in South Africa,…
The single-shot Johnson & Johnson vaccine is highly effective in preventing severe COVID-19, including newer variants, according to documents released by the US Food and Drug Administration.
The news on Wednesday came as the US regulator was set to convene an independent panel Friday that will likely vote to authorise the vaccine, making it the third available in the country hit hardest by the coronavirus pandemic.
In large clinical trials, the Johnson & Johnson vaccine’s efficacy against severe…
-
Business15 hours agoHere’s Warren Buffett’s advice as stocks reach record highs
-
General21 hours agoIsrael claims killing Houthi military chief of staff in strikes on rebel group leaders
-
Noosa News7 hours agoPolice launch new appeal for information about suspicious death of baby boy in Burpengary
-
General15 hours agoDemography Manifest